Sunday, 27 September 2020

US drugmaker reports promising early results from COVID-19 vaccine test

US biotech firm Moderna reported promising early results on Monday from the first clinical tests of an experimental vaccine against the novel coronavirus performed on a small number of volunteers.

A participant gets his injection in the first-phase trial of the coronavirus vaccine developed by Moderna, a company based in Cambridge, Massachusetts. Photograph: Ted S Warren/AP

The Cambridge, Massachusetts-based company said the vaccine candidate, mRNA-1273, appeared to produce an immune response in eight people who received it similar to that seen in people convalescing from the virus.

“These interim Phase 1 data, while early, demonstrate that vaccination with mRNA-1273 elicits an immune response of the magnitude caused by natural infection,” said Moderna’s chief medical officer Tal Zaks.

- paying the bills -

“These data substantiate our belief that mRNA-1273 has the potential to prevent COVID-19 disease and advance our ability to select a dose for pivotal trials,” Zaks said.

Moderna, which was founded nine years ago, said the vaccine “was generally safe and well tolerated” and that patients suffered no more than redness or soreness from the shots. In a conference call, Moderna CEO Stephane Bancel said the preliminary tests inspired confidence that mRNA-1273 has “a high probability to provide protection” against the virus.

Many different companies and institutions around the world are racing to develop a vaccine in record time, using different approaches. The World Health Organization has a list of 76 contenders. Moderna was the first in the world into clinical trials with an RNA vaccine, which uses a segment of genetic material from the virus itself, called messenger DNA, to provoke the immune system into making antibodies.

Moderna has so far only released results for the youngest group of volunteers. It intends to press ahead to the next stage of human trials involving 600 people shortly, with a much bigger trial involving thousands set to begin in July.

Sources: AFPnews

- paying the bills -

Q Costa Rica
Q Costa Rica
Reports by QCR staff

Related Articles

Harllan Hoepelmann is the first legislator to be diagnosed positive

(QCOSTARICA) Legislator Harllan Hoepelman, of the Nueva República, is the first...

They will give away 2,000 masks in the Desamparados park

(QCOSTARICA) The College of Physicians and Surgeons of Costa Rica (CMC)...

MOST READ

COVID-19 in Costa Rica: 1,890 cases and 39 deaths in 48 hours

(QCOSTARICA) The Ministry of Health reported on Monday, a total of 1,187 new cases of COVID-19 for Sunday and 703 for Monday, for a...

Brazil: Rio postpones Carnival over coronavirus

(Q24N) Rio de Janeiro's world-famous Carnival parade will not take place in February 2021 due to the coronavirus pandemic, officials announced Thursday. "We came to...

Reduction in electricity rates could be around the corner

(QCOSTARICA) The possibility of a significant reduction in electricity rates in the coming weeks increases due to key aspects, mainly due to the Instituto...

Costa Rica negotiates with 6 pharma for the COVID-19 vaccine

(QCOSTARICA) The government of Costa Rica has already started talks with six pharmaceutical companies for the future purchase of the COVID-19 vaccine. The acting Minister...

Blame the drivers: It’s not the posts, but the lack of road safety education

(QCOSTARICA) The installment of the flexible delineator folding posts on the Ruta 32, at a cost of ¢177 million colones Sunday morning is failing...

Which airlines are resuming flights to Costa Rica?

(QCOSTARICA) With the opening of borders, several airlines have resumed flights, others have modified their flight schedules, while others are still not serving Costa...

Let's Keep This Going!

To be updated with all the latest news and information about Costa Rica and Latin America.

Log In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Add to Collection

No Collections

Here you'll find all collections you've created before.